黄泽彬博士 医药高级投资分析师

黄博士专注于医疗健康和生物科技产业的分析研究和投资,擅长精准医疗、肿瘤治疗、细胞疗法、体外诊断、基因工程和生物制药领域。黄博士加入蓝海资本之前,在澳门大学健康科学学院进行了四年的博士后研究,重点研究癌症等重大疾病的发病机理,开发药物新靶点,以及研发精准医疗和基因治疗等新技术于临床治疗和产业化,在《Oncogene》等国际权威学术期刊发表多篇研究论文。黄博士获清华大学与北京协和医学院联合颁发的博士学位,师从王琳芳院士。

Zebin Huang, Ph.D
Senior Healthcare Analyst

Dr. Huang focuses on the research fields of precision medicine, cancer therapy, cell therapy, in vitro diagnostics, genetic engineering and biopharmacy. Prior to joining BOCG, Dr. Huang worked as a postdoctoral research fellow at the Faculty of Health Sciences at University of Macau for 4 years, focusing on exploring pathogenesis on major diseases such as cancer, new drug targets and new technologies such as precision medicine and gene therapy etc.. He had published research papers in international prestigious academic journals such as Oncogene. Dr. Huang received a joint Ph.D. degree from Tsinghua University and Peking Union Medical College.